Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients (Q28236175)
Jump to navigation
Jump to search
scientific article (publication date: March 2005)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients |
scientific article (publication date: March 2005) |
Statements
Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients (English)
0 references
1 March 2005
0 references
111
0 references
8
0 references
1012-8
0 references